Clozapine & Schizophrenia with Michael Cummings, MD

Dr. Michael Cummings, a leading psychopharmacologist and former head consultant at Patton State Hospital, shares his insights on treating schizophrenia with Clozapine. The discussion highlights the recent removal of the Clozapine REMS program, easing patient management. Key topics include optimal dosing practices, managing side effects, and drug interactions. Cummings also addresses the complexities of clozapine's associations with OCD and catatonia. The conversation underscores the importance of personalized strategies to improve patient outcomes while navigating the challenges of treatment.